These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32828536)

  • 1. A "keto-enol" plaque buster mechanism to diminish Alzheimer's β-Amyloid burden.
    Zoltán O; László P; Éva K; Béla V
    Biochem Biophys Res Commun; 2020 Oct; 532(1):82-87. PubMed ID: 32828536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Effect of Curcumin and (-)-Epigallocatechin-3-Gallate on the Aggregation of Aβ(1-40) Monomers by Means of Molecular Dynamics.
    Tavanti F; Pedone A; Menziani MC
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.
    Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL
    Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Binding to Beta Amyloid: A Computational Study.
    Rao PP; Mohamed T; Teckwani K; Tin G
    Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid β Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer's Disease.
    Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Tomiyama T; Tooyama I
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease.
    Brody DL; Jiang H; Wildburger N; Esparza TJ
    Alzheimers Res Ther; 2017 Aug; 9(1):62. PubMed ID: 28818091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
    Huo X; Zhang Y; Jin X; Li Y; Zhang L
    J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Anti-amyloid Compound DO1 Decreases Plaque Pathology and Neuroinflammation-Related Expression Changes in 5xFAD Transgenic Mice.
    Boeddrich A; Babila JT; Wiglenda T; Diez L; Jacob M; Nietfeld W; Huska MR; Haenig C; Groenke N; Buntru A; Blanc E; Meier JC; Vannoni E; Erck C; Friedrich B; Martens H; Neuendorf N; Schnoegl S; Wolfer DP; Loos M; Beule D; Andrade-Navarro MA; Wanker EE
    Cell Chem Biol; 2019 Jan; 26(1):109-120.e7. PubMed ID: 30472115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
    Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
    Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
    Sevigny J; Chiao P; Bussière T; Weinreb PH; Williams L; Maier M; Dunstan R; Salloway S; Chen T; Ling Y; O'Gorman J; Qian F; Arastu M; Li M; Chollate S; Brennan MS; Quintero-Monzon O; Scannevin RH; Arnold HM; Engber T; Rhodes K; Ferrero J; Hang Y; Mikulskis A; Grimm J; Hock C; Nitsch RM; Sandrock A
    Nature; 2016 Sep; 537(7618):50-6. PubMed ID: 27582220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease.
    Yanagisawa D; Shirai N; Amatsubo T; Taguchi H; Hirao K; Urushitani M; Morikawa S; Inubushi T; Kato M; Kato F; Morino K; Kimura H; Nakano I; Yoshida C; Okada T; Sano M; Wada Y; Wada KN; Yamamoto A; Tooyama I
    Biomaterials; 2010 May; 31(14):4179-85. PubMed ID: 20181392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration.
    Liu P; Reed MN; Kotilinek LA; Grant MK; Forster CL; Qiang W; Shapiro SL; Reichl JH; Chiang AC; Jankowsky JL; Wilmot CM; Cleary JP; Zahs KR; Ashe KH
    Cell Rep; 2015 Jun; 11(11):1760-71. PubMed ID: 26051935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
    Kaya I; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mathematical Model for Amyloid-𝜷 Aggregation in the Presence of Metal Ions: A Timescale Analysis for the Progress of Alzheimer Disease.
    Asili E; Yarahmadian S; Khani H; Sharify M
    Bull Math Biol; 2019 Jun; 81(6):1943-1964. PubMed ID: 30809773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
    Lee I; Yang J; Lee JH; Choe YS
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.